Powder: -20°C for 3 years | In solvent: -80°C for 1 year
2alpha,19alpha-Dihydroxy-3-oxo-urs-12-en-28-oic acid has anti-HIV activity. It shows an inhibitory effect on the activation of Epstein-Barr virus early antigen (EBV-EA) induced by 12-O-tetradecanoylphorbol-13-acetate (TPA) and causes a significant delay of two-stage carcinogenesis on mouse skin.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 1,798.00 | |
1 mL * 10 mM (in DMSO) | Inquiry | $ 2,168.00 |
Description | 2alpha,19alpha-Dihydroxy-3-oxo-urs-12-en-28-oic acid has anti-HIV activity. It shows an inhibitory effect on the activation of Epstein-Barr virus early antigen (EBV-EA) induced by 12-O-tetradecanoylphorbol-13-acetate (TPA) and causes a significant delay of two-stage carcinogenesis on mouse skin. |
Source |
Molecular Weight | 486.68 |
Formula | C30H46O5 |
CAS No. | 176983-21-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
2alpha,19alpha-Dihydroxy-3-oxo-urs-12-en-28-oic acid 176983-21-4 Microbiology/Virology Proteases/Proteasome HIV Protease 2alpha,19alpha Dihydroxy 3 oxo urs 12 en 28 oic acid 2a,19a-Dihydroxy-3-oxo-urs-12-en-28-oic acid 2alpha,19alphaDihydroxy3oxours12en28oic acid 2α,19α-Dihydroxy-3-oxo-urs-12-en-28-oic acid inhibitor inhibit